Alterations to the respiratory microbiome have been identified as a predisposing factor of interstitial lung diseases (ILD). In a study at CHEST 2018, researchers at Beaumont Health Systems studied the influence of bacterial ...
Oct 4, 2018
0
0
A new antibiotic, developed with support from Wellcome, has been approved for patient use in the US.
Jun 27, 2018
0
7
A new UCLA-led study provides clear evidence that cellular messengers in saliva may be able to regulate the growth of oral bacteria responsible for diseases, such as periodontitis and meningitis.
May 8, 2018
1
70
St. Jude Children's Research Hospital scientists have identified a key molecule that serves as a "security chief" to help the immune system quickly recognize and fight infections with dangerous gram-negative bacteria like ...
Mar 23, 2018
0
53
As resistance to existing antibiotics increases, new approaches to serious bacterial infections are needed. Now researchers at Lund University in Sweden, together with colleagues at the University of Massachusetts Medical ...
Dec 13, 2017
0
4
Encountering bacteria with innocent names such as Pseudomonas aeruginosa and Enterobacteriaceae can lead to hospitalisation and - in a worst-case scenario - can also be life-threatening. The bacteria, which cause infections ...
Nov 22, 2017
0
0
The nearly simultaneous emergence of a gene responsible for producing carbapenemases - enzymes that kill the most powerful antibiotics used against life-threatening, multidrug-resistant bacterial infections - coupled with ...
Nov 7, 2017
0
2
The golden age of antibiotics may be drawing to a close. The recent discovery of E. coli carrying mcr-1 and ndm-5—genes that make the bacterium immune to last-resort antibiotics—has left clinicians without an effective ...
Aug 21, 2017
0
5
Mouse models have advanced our understanding of immune function and disease in many ways but they have failed to account for the natural diversity in human immune responses. As a result, insights gained in the lab may be ...
Jul 26, 2017
0
22
Pathogenic bacteria are rapidly developing resistance to the arsenal of microbial therapies—and driving researchers to identify families of therapeutics with new modes of action. Recently, those include antibiotics that ...
Jul 25, 2017
0
1
